Stay updated on Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Sign up to get notified when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.

Latest updates to the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page
- Check6 days agoChange DetectedA new revision tag (v3.5.5) appears, replacing the previous v3.5.4. This update seems to be a small metadata revision and does not alter the main study details.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedRelated topics items 'Multiple myeloma', the 'related topics' header, and the 'MedlinePlus Genetics' link are no longer displayed in the page's context panel. This removes these related-topic links from the page while leaving the study details intact.SummaryDifference0.1%

- Check28 days agoChange DetectedA new Publication entry was added for Chari A et al., Blood 2017 article on daratumumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma. An older Publication entry for the MMY1001 update was removed from Publications.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded new related topics entries to the study page: 'Multiple myeloma' and 'MedlinePlus Genetics', enhancing cross-references and context on the record.SummaryDifference0.1%

- Check50 days agoChange DetectedA bibliographic citation entry related to multiple myeloma risk/progression is adjusted, and the page’s displayed site revision/version is updated from v3.5.2 to v3.5.3. These updates reflect general page content organization and site release metadata rather than changes to the clinical study itself.SummaryDifference0.2%

- Check57 days agoChange DetectedAdded Revision: v3.5.2. Deleted Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.